India plays a critical role in Bristol Myers Squibb’s global strategy
The reform is set to modernise how medicines are developed, authorised, and made available across the EU
More than five drug candidates from his team progressed to human trials including drugs like Rilematovir (Phase IIb), and Bedaquiline
In her previous roles, Menon led significant digital transformation efforts, implementing predictive analytics, automation
The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
Dr. Reddy's commits to achieving Net Zero greenhouse gas emissions across its value chain by FY 2045
The new site will produce next-generation synthetic medicine active pharmaceutical ingredients
The new site marks the company’s first operation in the region
Subscribe To Our Newsletter & Stay Updated